EE9900593A - Omeprasooli naatriumisool - Google Patents

Omeprasooli naatriumisool

Info

Publication number
EE9900593A
EE9900593A EEP199900593A EEP9900593A EE9900593A EE 9900593 A EE9900593 A EE 9900593A EE P199900593 A EEP199900593 A EE P199900593A EE P9900593 A EEP9900593 A EE P9900593A EE 9900593 A EE9900593 A EE 9900593A
Authority
EE
Estonia
Prior art keywords
sodium salt
omeprazole sodium
omeprazole
salt
sodium
Prior art date
Application number
EEP199900593A
Other languages
English (en)
Inventor
Gustavsson Anders
Kjellbom Kristina
Ymn Ingvar
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of EE9900593A publication Critical patent/EE9900593A/et
Publication of EE03613B1 publication Critical patent/EE03613B1/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
EEP199900593A 1997-06-27 1998-06-11 Omeprasooli naatriumisool,selle valmistamise protsess,seda sisaldav ravimkoostis ja selle kasutamine seedetrakti häirete ravimiseks EE03613B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9702483A SE510643C2 (sv) 1997-06-27 1997-06-27 Termodynamiskt stabil omeprazol natrium form B
PCT/SE1998/001124 WO1999000380A1 (en) 1997-06-27 1998-06-11 Omeprazole sodium salt

Publications (2)

Publication Number Publication Date
EE9900593A true EE9900593A (et) 2000-08-15
EE03613B1 EE03613B1 (et) 2002-02-15

Family

ID=20407555

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900593A EE03613B1 (et) 1997-06-27 1998-06-11 Omeprasooli naatriumisool,selle valmistamise protsess,seda sisaldav ravimkoostis ja selle kasutamine seedetrakti häirete ravimiseks

Country Status (35)

Country Link
US (1) US6207188B1 (et)
EP (2) EP1186602A3 (et)
JP (1) JP3377218B2 (et)
KR (1) KR100580987B1 (et)
CN (1) CN1134432C (et)
AR (1) AR013350A1 (et)
AT (1) ATE233756T1 (et)
AU (1) AU750239B2 (et)
BR (1) BR9810483A (et)
CA (1) CA2294614C (et)
CZ (1) CZ296723B6 (et)
DE (1) DE69811892T2 (et)
DK (1) DK0991641T3 (et)
EE (1) EE03613B1 (et)
EG (1) EG24224A (et)
ES (1) ES2191944T3 (et)
HK (1) HK1026699A1 (et)
HU (1) HU227976B1 (et)
ID (1) ID24829A (et)
IL (2) IL133559A0 (et)
IS (1) IS1946B (et)
MY (1) MY127871A (et)
NO (1) NO318245B1 (et)
NZ (1) NZ501929A (et)
PL (1) PL190869B1 (et)
PT (1) PT991641E (et)
RU (1) RU2186778C2 (et)
SA (1) SA98190410B1 (et)
SE (1) SE510643C2 (et)
SK (1) SK283958B6 (et)
TR (1) TR199903270T2 (et)
TW (1) TW483758B (et)
UA (1) UA58556C2 (et)
WO (1) WO1999000380A1 (et)
ZA (1) ZA985317B (et)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
EP0909323B1 (en) 1996-01-04 2007-02-28 Novartis Vaccines and Diagnostics, Inc. Helicobacter pylori bacterioferritin
SE510643C2 (sv) 1997-06-27 1999-06-14 Astra Ab Termodynamiskt stabil omeprazol natrium form B
SE9900274D0 (sv) * 1999-01-28 1999-01-28 Astra Ab New compound
IL145220A0 (en) * 1999-05-20 2002-06-30 Par Pharmaceutical Inc Stabilized composition based on pyridinyl-sulfinyl-benzimidazoles and process
SE9903831D0 (sv) 1999-10-22 1999-10-22 Astra Ab Formulation of substituted benzimidazoles
SE0000774D0 (sv) 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
SE0000773D0 (sv) * 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
AU5248601A (en) * 2000-05-15 2001-11-26 Ranbaxy Laboratories Limited Novel amorphous form of omeprazole salts
ATE342263T1 (de) 2000-08-04 2006-11-15 Takeda Pharmaceutical Salze von benzimidazol-derivaten und deren verwendung
CA2419067C (en) 2000-08-18 2008-12-23 Takeda Chemical Industries, Ltd. Injectable composition comprising benzimidazole compound and strong alkali
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
US6926907B2 (en) 2001-06-01 2005-08-09 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
KR100433735B1 (ko) * 2001-06-27 2004-06-04 주식회사 씨트리 결정형 ⅰ을 갖는 란소프라졸의 제조방법
SE0102993D0 (sv) 2001-09-07 2001-09-07 Astrazeneca Ab New self emulsifying drug delivery system
US20040235903A1 (en) * 2002-10-22 2004-11-25 Khanna Mahavir Singh Amorphous form of esomeprazole salts
US20070060556A1 (en) 2003-05-05 2007-03-15 Yatendra Kumar Barium salt of benzimidazole derivative
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
FR2871800B1 (fr) * 2004-06-17 2006-08-25 Sidem Pharma Sa Sa Sel de sodium monohydrate du s-tenatoprazole et application en therapeutique
AU2005257709C1 (en) * 2004-06-24 2011-02-24 Astrazeneca Ab New process for the preparation of crystal modifications for use in the preparation of esomeprazole sodium salt
US20060160783A1 (en) * 2004-12-30 2006-07-20 Transform Pharmaceuticals, Inc. Novel omeprazole forms and related methods
US8247566B2 (en) * 2005-06-08 2012-08-21 Lek Pharmaceuticals D.D. Crystalline solvate of omeprazole sodium
US9220698B2 (en) 2008-09-09 2015-12-29 Pozen Inc. Method for delivering a pharmaceutical composition to patient in need thereof
CN101412710B (zh) * 2008-12-16 2010-04-21 海南百那医药发展有限公司 一种奥美拉唑钠化合物及其制法
EA201290026A1 (ru) 2009-06-25 2012-07-30 Астразенека Аб Способ лечения пациента, имеющего риск развития язвы, связанной с приемом нестероидных противовоспалительных средств (nsaid)
EP2445344A4 (en) * 2009-06-25 2013-01-23 Pozen Inc METHOD FOR THE TREATMENT OF A PATIENT REQUIRED BY ASPIRIN THERAPY
CN102351846B (zh) * 2011-09-07 2012-08-22 周晓东 一种新的奥美拉唑钠化合物及其药物组合物
CN102319223B (zh) * 2011-09-21 2013-06-19 石药集团欧意药业有限公司 一种埃索美拉唑冻干制剂及其制备方法
CN102512380B (zh) * 2011-12-20 2013-04-17 海南锦瑞制药股份有限公司 一种以奥美拉唑钠为活性成分的冻干粉针剂及其制备方法
UA115139C2 (uk) 2011-12-28 2017-09-25 Поузен Інк. Спосіб доставки фармацевтичної композиції, яка містить омепразол й ацетилсаліцилову кислоту, пацієнту
CN102827147B (zh) * 2012-09-13 2013-08-07 山东罗欣药业股份有限公司 一种奥美拉唑钠晶体化合物及含有该晶体化合物的药物组合物
CN102871973A (zh) * 2012-10-16 2013-01-16 浙江亚太药业股份有限公司 一种奥美拉唑钠冻干制剂及其制备方法
CN103012371B (zh) * 2013-01-05 2014-02-12 宁辉 奥美拉唑钠结晶化合物、其制备方法及其药物组合物
CN103570687B (zh) * 2013-11-15 2015-01-07 悦康药业集团有限公司 一种奥美拉唑钠晶体化合物
CN104788426B (zh) * 2015-04-02 2015-12-30 天津大学 一种奥美拉唑钠半水合物及其制备方法
WO2024075017A1 (en) 2022-10-04 2024-04-11 Zabirnyk Arsenii Inhibition of aortic valve calcification

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2719916A1 (de) * 1977-05-04 1978-11-09 Kali Chemie Pharma Gmbh Verfahren zur herstellung von 2,9-dioxatricyclo eckige klammer auf 4,3,1,0 hoch 3,7 eckige klammer zu decanen
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
SE8301182D0 (sv) * 1983-03-04 1983-03-04 Haessle Ab Novel compounds
GB2189698A (en) 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
ES2023778A6 (es) * 1990-12-12 1992-02-01 Genesis Para La Investigacion Procedimiento para preparar sales alcalinas del omeprazol
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
WO1995032957A1 (en) * 1994-05-27 1995-12-07 Astra Aktiebolag Novel ethoxycarbonyloxymethyl derivatives of substituted benzimidazoles
ES2316333T3 (es) 1994-07-08 2009-04-16 Astrazeneca Ab Forma de dosificacion en tabletas constituida por unidades multiples.
SE504459C2 (sv) * 1994-07-15 1997-02-17 Astra Ab Förfarande för framställning av substituerade sulfoxider
CN1042423C (zh) * 1995-05-25 1999-03-10 常州市第四制药厂 奥美拉唑盐水合物及其制备方法
AU5982298A (en) * 1997-03-07 1998-09-29 A/S Gea Farmaceutisk Fabrik Process for the preparation of 2-{{(2-pyridinyl)me thyl}sulfinyl}-1h-benzimidazoles and novel compounds of use for such purpos
EP0968204A1 (en) * 1997-03-07 2000-01-05 A/S GEA Farmaceutisk Fabrik Process for the preparation of 2- (2-pyridinyl)methyl]sulfinyl]-1h-benzimidazoles and novel compounds of use for such purpose
SE510643C2 (sv) 1997-06-27 1999-06-14 Astra Ab Termodynamiskt stabil omeprazol natrium form B

Also Published As

Publication number Publication date
AR013350A1 (es) 2000-12-27
HUP0003017A3 (en) 2002-01-28
IL133559A (en) 2006-04-10
WO1999000380A1 (en) 1999-01-07
NO996440L (no) 2000-02-08
CN1134432C (zh) 2004-01-14
TW483758B (en) 2002-04-21
HUP0003017A2 (hu) 2001-06-28
ID24829A (id) 2000-08-24
EP1186602A3 (en) 2002-03-27
JP3377218B2 (ja) 2003-02-17
DE69811892D1 (de) 2003-04-10
IL133559A0 (en) 2001-04-30
ZA985317B (en) 1999-01-11
HK1026699A1 (en) 2000-12-22
AU750239B2 (en) 2002-07-11
SE510643C2 (sv) 1999-06-14
EP1186602A2 (en) 2002-03-13
CA2294614A1 (en) 1999-01-07
ES2191944T3 (es) 2003-09-16
SE9702483D0 (sv) 1997-06-27
PL337735A1 (en) 2000-08-28
CA2294614C (en) 2002-01-08
AU8135398A (en) 1999-01-19
RU2186778C2 (ru) 2002-08-10
SE9702483L (sv) 1998-12-28
NO318245B1 (no) 2005-02-21
HU227976B1 (en) 2012-07-30
BR9810483A (pt) 2000-09-12
MY127871A (en) 2006-12-29
SK172999A3 (en) 2000-07-11
ATE233756T1 (de) 2003-03-15
CZ296723B6 (cs) 2006-05-17
TR199903270T2 (xx) 2000-07-21
KR20010014165A (ko) 2001-02-26
DK0991641T3 (da) 2003-05-19
EE03613B1 (et) 2002-02-15
US6207188B1 (en) 2001-03-27
SA98190410B1 (ar) 2006-06-10
IS5314A (is) 1999-12-21
JP2001508805A (ja) 2001-07-03
NO996440D0 (no) 1999-12-23
EP0991641A1 (en) 2000-04-12
IS1946B (is) 2004-10-13
CZ469999A3 (cs) 2000-08-16
NZ501929A (en) 2001-06-29
PT991641E (pt) 2003-06-30
UA58556C2 (uk) 2003-08-15
SK283958B6 (sk) 2004-06-08
PL190869B1 (pl) 2006-02-28
KR100580987B1 (ko) 2006-05-17
EG24224A (en) 2008-11-10
DE69811892T2 (de) 2004-03-04
EP0991641B1 (en) 2003-03-05
CN1261362A (zh) 2000-07-26

Similar Documents

Publication Publication Date Title
NO996440L (no) Omeprazol-natriumsalt
DK1005446T3 (da) N-aroylphenylalaninderivater
ATE235220T1 (de) Resorcinderivate
ID22781A (id) Turunan-turunan nikotinamida
ATE284385T1 (de) Sulfonamidderivate
DE69817186D1 (de) Diaminorhodamin-derivate
DE69802569D1 (de) Aufhängungseinrichtung
DE29703258U1 (de) Aufhängevorrichtung
ATE255098T1 (de) Substituierte chromanderivate
DE69841086D1 (de) 5-Deoxy-Cytidin-Derivate
ATE255099T1 (de) Substituierte chromanderivate
ID18027A (id) Garam amina
DE69829682D1 (de) Cis-disubstituierte aminocycloalkyl-pyrrolidin-derivate
ATE241275T1 (de) Phosphoniumsalz-zusammensetzung
DE69828780D1 (de) Amidinocamptpthecin-derivate
NO981495D0 (no) Phenoxymetylpiperidin-derivater
DE69813264D1 (de) Kleiderbügel
DK0966437T3 (da) 5-Aroylnaphthalenderivater
DK1015447T3 (da) Piperidinylmethyloxazolidinonderivat
DE69814731D1 (de) Kleiderbügel
DE69804153T2 (de) Aufhänger
DE29700387U1 (de) Abhänger
DE29718550U1 (de) Aufhängevorrichtung
DE29701544U1 (de) Kleiderbügel
FR2766076B1 (fr) Cintre-presentoir

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20160611